Project Updates

Plant C has fully updated serialisation and packaging capabilities and supports contract manufacturing. Credit: Upsher-Smith Laboratories, LLC.

Project name: Upsher-Smiths Pharmaceutical Manufacturing Facility, US 
Location: Maple Grove, Minnesota 
Project type: Pharmaceutical manufacturing facility 
Investment: $100m 

Upsher-Smith Laboratories has opened a new facility known as Plant C. The facility has increased the capacity for packaging, distribution, logistics, and warehousing of the company’s products, which include more than 150 branded and generic products.

Kite Pharma’s Viral Vector Manufacturing Facility in Oceanside, California. Credit: Kite Pharma

Project name: Kite Pharma’s Viral Vector Manufacturing Facility 
Location: Oceanside, California, US 
Project type: Viral vector manufacturing facility 
Approved for Commercial Production: October 2022

Gilead Sciences subsidiary Kite Pharma’ facility is being used for manufacturing viral vectors to produce cell therapy, as well as the company’s chimeric antigen receptor T (CAR T) cell therapy Yescarta.

Evonik's GMP facility at its Hanau site. Credit: Evonik.

Project name: Evonik’s Pharmaceutical Lipids Manufacturing Facility

Location: Hanau, Germany 
Project type: Pharmaceutical lipids manufacturing facility 
Opened: March 2023 

Evonik opened a new GMP facility to manufacture pharmaceutical lipids for clinical development and small-scale commercialisation at its existing site in Hanau.